nodes	percent_of_prediction	percent_of_DWPC	metapath
Mechlorethamine—Alkylating Activity—Mitomycin—urinary bladder cancer	0.542	0.569	CiPCiCtD
Mechlorethamine—Alkylating Activity—Thiotepa—urinary bladder cancer	0.411	0.431	CiPCiCtD
Mechlorethamine—Azoospermia—Thiotepa—urinary bladder cancer	0.00184	0.0394	CcSEcCtD
Mechlorethamine—Azoospermia—Gemcitabine—urinary bladder cancer	0.00154	0.0332	CcSEcCtD
Mechlorethamine—Azoospermia—Cisplatin—urinary bladder cancer	0.00144	0.0309	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Thiotepa—urinary bladder cancer	0.000831	0.0179	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Mitomycin—urinary bladder cancer	0.000824	0.0177	CcSEcCtD
Mechlorethamine—Lymphopenia—Gemcitabine—urinary bladder cancer	0.000813	0.0175	CcSEcCtD
Mechlorethamine—Azoospermia—Methotrexate—urinary bladder cancer	0.00079	0.017	CcSEcCtD
Mechlorethamine—Azoospermia—Epirubicin—urinary bladder cancer	0.000739	0.0159	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Fluorouracil—urinary bladder cancer	0.000688	0.0148	CcSEcCtD
Mechlorethamine—Azoospermia—Doxorubicin—urinary bladder cancer	0.000684	0.0147	CcSEcCtD
Mechlorethamine—Pancytopenia—Mitomycin—urinary bladder cancer	0.000586	0.0126	CcSEcCtD
Mechlorethamine—Blister—Fluorouracil—urinary bladder cancer	0.000567	0.0122	CcSEcCtD
Mechlorethamine—Amenorrhoea—Thiotepa—urinary bladder cancer	0.000563	0.0121	CcSEcCtD
Mechlorethamine—Oliguria—Thiotepa—urinary bladder cancer	0.000537	0.0115	CcSEcCtD
Mechlorethamine—Petechiae—Gemcitabine—urinary bladder cancer	0.000506	0.0109	CcSEcCtD
Mechlorethamine—Infection—Carboplatin—urinary bladder cancer	0.000468	0.0101	CcSEcCtD
Mechlorethamine—Alopecia—Mitomycin—urinary bladder cancer	0.000436	0.00937	CcSEcCtD
Mechlorethamine—Azotaemia—Methotrexate—urinary bladder cancer	0.000399	0.00858	CcSEcCtD
Mechlorethamine—Lymphopenia—Epirubicin—urinary bladder cancer	0.000389	0.00836	CcSEcCtD
Mechlorethamine—Leukopenia—Mitomycin—urinary bladder cancer	0.000385	0.00827	CcSEcCtD
Mechlorethamine—Pruritus—Valrubicin—urinary bladder cancer	0.00036	0.00774	CcSEcCtD
Mechlorethamine—Lymphopenia—Doxorubicin—urinary bladder cancer	0.00036	0.00773	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Methotrexate—urinary bladder cancer	0.000358	0.00769	CcSEcCtD
Mechlorethamine—Diarrhoea—Valrubicin—urinary bladder cancer	0.000348	0.00749	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.000343	0.00738	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.000343	0.00737	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Epirubicin—urinary bladder cancer	0.000335	0.00719	CcSEcCtD
Mechlorethamine—Anorexia—Mitomycin—urinary bladder cancer	0.000334	0.00718	CcSEcCtD
Mechlorethamine—Vomiting—Valrubicin—urinary bladder cancer	0.000324	0.00696	CcSEcCtD
Mechlorethamine—Rash—Valrubicin—urinary bladder cancer	0.000321	0.0069	CcSEcCtD
Mechlorethamine—Dermatitis—Valrubicin—urinary bladder cancer	0.000321	0.00689	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.000316	0.00679	CcSEcCtD
Mechlorethamine—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.000312	0.0067	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.000311	0.00667	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Doxorubicin—urinary bladder cancer	0.00031	0.00665	CcSEcCtD
Mechlorethamine—Decreased appetite—Mitomycin—urinary bladder cancer	0.000305	0.00655	CcSEcCtD
Mechlorethamine—Nausea—Valrubicin—urinary bladder cancer	0.000302	0.0065	CcSEcCtD
Mechlorethamine—Pancytopenia—Thiotepa—urinary bladder cancer	0.000295	0.00633	CcSEcCtD
Mechlorethamine—Herpes zoster—Methotrexate—urinary bladder cancer	0.000283	0.00607	CcSEcCtD
Mechlorethamine—Thrombosis—Epirubicin—urinary bladder cancer	0.000281	0.00604	CcSEcCtD
Mechlorethamine—Blister—Epirubicin—urinary bladder cancer	0.000276	0.00593	CcSEcCtD
Mechlorethamine—Skin ulcer—Methotrexate—urinary bladder cancer	0.000273	0.00587	CcSEcCtD
Mechlorethamine—Jaundice—Thiotepa—urinary bladder cancer	0.00027	0.00579	CcSEcCtD
Mechlorethamine—Herpes zoster—Epirubicin—urinary bladder cancer	0.000264	0.00568	CcSEcCtD
Mechlorethamine—Thrombosis—Doxorubicin—urinary bladder cancer	0.00026	0.00559	CcSEcCtD
Mechlorethamine—Petechiae—Methotrexate—urinary bladder cancer	0.000259	0.00556	CcSEcCtD
Mechlorethamine—Agranulocytosis—Thiotepa—urinary bladder cancer	0.000258	0.00555	CcSEcCtD
Mechlorethamine—Skin ulcer—Epirubicin—urinary bladder cancer	0.000256	0.00549	CcSEcCtD
Mechlorethamine—Blister—Doxorubicin—urinary bladder cancer	0.000256	0.00549	CcSEcCtD
Mechlorethamine—Haemoglobin—Thiotepa—urinary bladder cancer	0.00025	0.00536	CcSEcCtD
Mechlorethamine—Haemorrhage—Thiotepa—urinary bladder cancer	0.000248	0.00534	CcSEcCtD
Mechlorethamine—Pancytopenia—Gemcitabine—urinary bladder cancer	0.000248	0.00532	CcSEcCtD
Mechlorethamine—Herpes zoster—Doxorubicin—urinary bladder cancer	0.000245	0.00526	CcSEcCtD
Mechlorethamine—Pancytopenia—Fluorouracil—urinary bladder cancer	0.000244	0.00524	CcSEcCtD
Mechlorethamine—Petechiae—Epirubicin—urinary bladder cancer	0.000242	0.0052	CcSEcCtD
Mechlorethamine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00024	0.00516	CcSEcCtD
Mechlorethamine—Skin ulcer—Doxorubicin—urinary bladder cancer	0.000237	0.00508	CcSEcCtD
Mechlorethamine—Tinnitus—Thiotepa—urinary bladder cancer	0.000231	0.00497	CcSEcCtD
Mechlorethamine—Pancytopenia—Cisplatin—urinary bladder cancer	0.000231	0.00496	CcSEcCtD
Mechlorethamine—Oliguria—Methotrexate—urinary bladder cancer	0.000231	0.00496	CcSEcCtD
Mechlorethamine—Amenorrhoea—Epirubicin—urinary bladder cancer	0.000227	0.00487	CcSEcCtD
Mechlorethamine—Petechiae—Doxorubicin—urinary bladder cancer	0.000224	0.00481	CcSEcCtD
Mechlorethamine—Vomiting—Mitomycin—urinary bladder cancer	0.000223	0.00479	CcSEcCtD
Mechlorethamine—Rash—Mitomycin—urinary bladder cancer	0.000221	0.00475	CcSEcCtD
Mechlorethamine—Dermatitis—Mitomycin—urinary bladder cancer	0.000221	0.00475	CcSEcCtD
Mechlorethamine—Alopecia—Thiotepa—urinary bladder cancer	0.000219	0.00471	CcSEcCtD
Mechlorethamine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000217	0.00467	CcSEcCtD
Mechlorethamine—Oliguria—Epirubicin—urinary bladder cancer	0.000216	0.00464	CcSEcCtD
Mechlorethamine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000213	0.00459	CcSEcCtD
Mechlorethamine—Pancytopenia—Etoposide—urinary bladder cancer	0.000212	0.00455	CcSEcCtD
Mechlorethamine—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00021	0.00451	CcSEcCtD
Mechlorethamine—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.00021	0.0045	CcSEcCtD
Mechlorethamine—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000209	0.00449	CcSEcCtD
Mechlorethamine—Nausea—Mitomycin—urinary bladder cancer	0.000208	0.00448	CcSEcCtD
Mechlorethamine—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000206	0.00444	CcSEcCtD
Mechlorethamine—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000205	0.00441	CcSEcCtD
Mechlorethamine—Oliguria—Doxorubicin—urinary bladder cancer	0.0002	0.0043	CcSEcCtD
Mechlorethamine—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000197	0.00424	CcSEcCtD
Mechlorethamine—Jaundice—Etoposide—urinary bladder cancer	0.000194	0.00416	CcSEcCtD
Mechlorethamine—Leukopenia—Thiotepa—urinary bladder cancer	0.000193	0.00416	CcSEcCtD
Mechlorethamine—Agranulocytosis—Etoposide—urinary bladder cancer	0.000185	0.00398	CcSEcCtD
Mechlorethamine—Alopecia—Gemcitabine—urinary bladder cancer	0.000185	0.00397	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000183	0.00393	CcSEcCtD
Mechlorethamine—Tinnitus—Cisplatin—urinary bladder cancer	0.000182	0.0039	CcSEcCtD
Mechlorethamine—Alopecia—Fluorouracil—urinary bladder cancer	0.000181	0.0039	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.000178	0.00383	CcSEcCtD
Mechlorethamine—Infection—Thiotepa—urinary bladder cancer	0.000175	0.00377	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000173	0.00371	CcSEcCtD
Mechlorethamine—Alopecia—Cisplatin—urinary bladder cancer	0.000172	0.0037	CcSEcCtD
Mechlorethamine—Skin disorder—Thiotepa—urinary bladder cancer	0.000171	0.00368	CcSEcCtD
Mechlorethamine—Erythema multiforme—Etoposide—urinary bladder cancer	0.000169	0.00362	CcSEcCtD
Mechlorethamine—Anorexia—Thiotepa—urinary bladder cancer	0.000168	0.00361	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000167	0.00359	CcSEcCtD
Mechlorethamine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000163	0.0035	CcSEcCtD
Mechlorethamine—Leukopenia—Fluorouracil—urinary bladder cancer	0.00016	0.00344	CcSEcCtD
Mechlorethamine—Alopecia—Etoposide—urinary bladder cancer	0.000158	0.00339	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000154	0.00332	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000154	0.0033	CcSEcCtD
Mechlorethamine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000153	0.00329	CcSEcCtD
Mechlorethamine—Leukopenia—Cisplatin—urinary bladder cancer	0.000152	0.00326	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000151	0.00325	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000148	0.00319	CcSEcCtD
Mechlorethamine—Infection—Gemcitabine—urinary bladder cancer	0.000147	0.00317	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000146	0.00314	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000145	0.00312	CcSEcCtD
Mechlorethamine—Infection—Fluorouracil—urinary bladder cancer	0.000145	0.00311	CcSEcCtD
Mechlorethamine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000144	0.0031	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000143	0.00308	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000143	0.00307	CcSEcCtD
Mechlorethamine—Anorexia—Gemcitabine—urinary bladder cancer	0.000141	0.00304	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00014	0.00301	CcSEcCtD
Mechlorethamine—Vertigo—Etoposide—urinary bladder cancer	0.000139	0.003	CcSEcCtD
Mechlorethamine—Anorexia—Fluorouracil—urinary bladder cancer	0.000139	0.00299	CcSEcCtD
Mechlorethamine—Leukopenia—Etoposide—urinary bladder cancer	0.000139	0.00299	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000138	0.00297	CcSEcCtD
Mechlorethamine—Infection—Cisplatin—urinary bladder cancer	0.000137	0.00295	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000135	0.00291	CcSEcCtD
Mechlorethamine—Skin disorder—Cisplatin—urinary bladder cancer	0.000134	0.00289	CcSEcCtD
Mechlorethamine—Anorexia—Cisplatin—urinary bladder cancer	0.000132	0.00283	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000131	0.00282	CcSEcCtD
Mechlorethamine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00013	0.00279	CcSEcCtD
Mechlorethamine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000129	0.00277	CcSEcCtD
Mechlorethamine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000127	0.00273	CcSEcCtD
Mechlorethamine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000127	0.00272	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000127	0.00272	CcSEcCtD
Mechlorethamine—Infection—Etoposide—urinary bladder cancer	0.000126	0.0027	CcSEcCtD
Mechlorethamine—Pruritus—Thiotepa—urinary bladder cancer	0.000125	0.00268	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000124	0.00267	CcSEcCtD
Mechlorethamine—Skin disorder—Etoposide—urinary bladder cancer	0.000123	0.00264	CcSEcCtD
Mechlorethamine—Anorexia—Etoposide—urinary bladder cancer	0.000121	0.0026	CcSEcCtD
Mechlorethamine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000121	0.00259	CcSEcCtD
Mechlorethamine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00012	0.00258	CcSEcCtD
Mechlorethamine—Depression—Methotrexate—urinary bladder cancer	0.000119	0.00255	CcSEcCtD
Mechlorethamine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000119	0.00255	CcSEcCtD
Mechlorethamine—Vomiting—Thiotepa—urinary bladder cancer	0.000112	0.00241	CcSEcCtD
Mechlorethamine—Rash—Thiotepa—urinary bladder cancer	0.000111	0.00239	CcSEcCtD
Mechlorethamine—Dermatitis—Thiotepa—urinary bladder cancer	0.000111	0.00239	CcSEcCtD
Mechlorethamine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000111	0.00239	CcSEcCtD
Mechlorethamine—Decreased appetite—Etoposide—urinary bladder cancer	0.00011	0.00237	CcSEcCtD
Mechlorethamine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00011	0.00236	CcSEcCtD
Mechlorethamine—Jaundice—Epirubicin—urinary bladder cancer	0.000109	0.00233	CcSEcCtD
Mechlorethamine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000107	0.00231	CcSEcCtD
Mechlorethamine—Haemoglobin—Methotrexate—urinary bladder cancer	0.000107	0.00231	CcSEcCtD
Mechlorethamine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000107	0.0023	CcSEcCtD
Mechlorethamine—Pruritus—Gemcitabine—urinary bladder cancer	0.000105	0.00226	CcSEcCtD
Mechlorethamine—Nausea—Thiotepa—urinary bladder cancer	0.000105	0.00225	CcSEcCtD
Mechlorethamine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000104	0.00223	CcSEcCtD
Mechlorethamine—Pruritus—Fluorouracil—urinary bladder cancer	0.000103	0.00222	CcSEcCtD
Mechlorethamine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000102	0.00219	CcSEcCtD
Mechlorethamine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000102	0.00218	CcSEcCtD
Mechlorethamine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000101	0.00217	CcSEcCtD
Mechlorethamine—Haemoglobin—Epirubicin—urinary bladder cancer	0.0001	0.00216	CcSEcCtD
Mechlorethamine—Jaundice—Doxorubicin—urinary bladder cancer	0.0001	0.00216	CcSEcCtD
Mechlorethamine—Haemorrhage—Epirubicin—urinary bladder cancer	0.0001	0.00215	CcSEcCtD
Mechlorethamine—Diarrhoea—Fluorouracil—urinary bladder cancer	9.98e-05	0.00215	CcSEcCtD
Mechlorethamine—Tinnitus—Methotrexate—urinary bladder cancer	9.96e-05	0.00214	CcSEcCtD
Mechlorethamine—Agranulocytosis—Doxorubicin—urinary bladder cancer	9.62e-05	0.00207	CcSEcCtD
Mechlorethamine—Diarrhoea—Cisplatin—urinary bladder cancer	9.46e-05	0.00203	CcSEcCtD
Mechlorethamine—Erythema multiforme—Epirubicin—urinary bladder cancer	9.45e-05	0.00203	CcSEcCtD
Mechlorethamine—Alopecia—Methotrexate—urinary bladder cancer	9.44e-05	0.00203	CcSEcCtD
Mechlorethamine—Vomiting—Gemcitabine—urinary bladder cancer	9.43e-05	0.00203	CcSEcCtD
Mechlorethamine—Rash—Gemcitabine—urinary bladder cancer	9.36e-05	0.00201	CcSEcCtD
Mechlorethamine—Dermatitis—Gemcitabine—urinary bladder cancer	9.35e-05	0.00201	CcSEcCtD
Mechlorethamine—Hypersensitivity—Etoposide—urinary bladder cancer	9.34e-05	0.00201	CcSEcCtD
Mechlorethamine—Tinnitus—Epirubicin—urinary bladder cancer	9.32e-05	0.002	CcSEcCtD
Mechlorethamine—Haemoglobin—Doxorubicin—urinary bladder cancer	9.3e-05	0.002	CcSEcCtD
Mechlorethamine—Vomiting—Fluorouracil—urinary bladder cancer	9.28e-05	0.00199	CcSEcCtD
Mechlorethamine—Haemorrhage—Doxorubicin—urinary bladder cancer	9.25e-05	0.00199	CcSEcCtD
Mechlorethamine—Rash—Fluorouracil—urinary bladder cancer	9.2e-05	0.00198	CcSEcCtD
Mechlorethamine—Dermatitis—Fluorouracil—urinary bladder cancer	9.19e-05	0.00197	CcSEcCtD
Mechlorethamine—Pruritus—Etoposide—urinary bladder cancer	8.96e-05	0.00193	CcSEcCtD
Mechlorethamine—Alopecia—Epirubicin—urinary bladder cancer	8.83e-05	0.0019	CcSEcCtD
Mechlorethamine—Nausea—Gemcitabine—urinary bladder cancer	8.81e-05	0.00189	CcSEcCtD
Mechlorethamine—Vomiting—Cisplatin—urinary bladder cancer	8.79e-05	0.00189	CcSEcCtD
Mechlorethamine—Erythema multiforme—Doxorubicin—urinary bladder cancer	8.75e-05	0.00188	CcSEcCtD
Mechlorethamine—Rash—Cisplatin—urinary bladder cancer	8.72e-05	0.00187	CcSEcCtD
Mechlorethamine—Dermatitis—Cisplatin—urinary bladder cancer	8.71e-05	0.00187	CcSEcCtD
Mechlorethamine—Diarrhoea—Etoposide—urinary bladder cancer	8.67e-05	0.00186	CcSEcCtD
Mechlorethamine—Nausea—Fluorouracil—urinary bladder cancer	8.67e-05	0.00186	CcSEcCtD
Mechlorethamine—Tinnitus—Doxorubicin—urinary bladder cancer	8.62e-05	0.00185	CcSEcCtD
Mechlorethamine—Vertigo—Methotrexate—urinary bladder cancer	8.36e-05	0.0018	CcSEcCtD
Mechlorethamine—Leukopenia—Methotrexate—urinary bladder cancer	8.32e-05	0.00179	CcSEcCtD
Mechlorethamine—Nausea—Cisplatin—urinary bladder cancer	8.22e-05	0.00177	CcSEcCtD
Mechlorethamine—Alopecia—Doxorubicin—urinary bladder cancer	8.17e-05	0.00176	CcSEcCtD
Mechlorethamine—Vomiting—Etoposide—urinary bladder cancer	8.06e-05	0.00173	CcSEcCtD
Mechlorethamine—Rash—Etoposide—urinary bladder cancer	7.99e-05	0.00172	CcSEcCtD
Mechlorethamine—Dermatitis—Etoposide—urinary bladder cancer	7.98e-05	0.00172	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	7.86e-05	0.00169	CcSEcCtD
Mechlorethamine—Vertigo—Epirubicin—urinary bladder cancer	7.82e-05	0.00168	CcSEcCtD
Mechlorethamine—Leukopenia—Epirubicin—urinary bladder cancer	7.79e-05	0.00167	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Methotrexate—urinary bladder cancer	7.59e-05	0.00163	CcSEcCtD
Mechlorethamine—Infection—Methotrexate—urinary bladder cancer	7.54e-05	0.00162	CcSEcCtD
Mechlorethamine—Nausea—Etoposide—urinary bladder cancer	7.53e-05	0.00162	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Methotrexate—urinary bladder cancer	7.43e-05	0.0016	CcSEcCtD
Mechlorethamine—Skin disorder—Methotrexate—urinary bladder cancer	7.37e-05	0.00158	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	7.36e-05	0.00158	CcSEcCtD
Mechlorethamine—Vertigo—Doxorubicin—urinary bladder cancer	7.23e-05	0.00155	CcSEcCtD
Mechlorethamine—Anorexia—Methotrexate—urinary bladder cancer	7.23e-05	0.00155	CcSEcCtD
Mechlorethamine—Leukopenia—Doxorubicin—urinary bladder cancer	7.21e-05	0.00155	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Epirubicin—urinary bladder cancer	7.1e-05	0.00153	CcSEcCtD
Mechlorethamine—Infection—Epirubicin—urinary bladder cancer	7.06e-05	0.00152	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Epirubicin—urinary bladder cancer	6.95e-05	0.00149	CcSEcCtD
Mechlorethamine—Skin disorder—Epirubicin—urinary bladder cancer	6.9e-05	0.00148	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	6.81e-05	0.00146	CcSEcCtD
Mechlorethamine—Anorexia—Epirubicin—urinary bladder cancer	6.77e-05	0.00145	CcSEcCtD
Mechlorethamine—Decreased appetite—Methotrexate—urinary bladder cancer	6.6e-05	0.00142	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	6.57e-05	0.00141	CcSEcCtD
Mechlorethamine—Infection—Doxorubicin—urinary bladder cancer	6.53e-05	0.0014	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	6.43e-05	0.00138	CcSEcCtD
Mechlorethamine—Skin disorder—Doxorubicin—urinary bladder cancer	6.38e-05	0.00137	CcSEcCtD
Mechlorethamine—Anorexia—Doxorubicin—urinary bladder cancer	6.26e-05	0.00135	CcSEcCtD
Mechlorethamine—Decreased appetite—Epirubicin—urinary bladder cancer	6.17e-05	0.00133	CcSEcCtD
Mechlorethamine—Decreased appetite—Doxorubicin—urinary bladder cancer	5.71e-05	0.00123	CcSEcCtD
Mechlorethamine—Hypersensitivity—Methotrexate—urinary bladder cancer	5.59e-05	0.0012	CcSEcCtD
Mechlorethamine—Pruritus—Methotrexate—urinary bladder cancer	5.37e-05	0.00115	CcSEcCtD
Mechlorethamine—Hypersensitivity—Epirubicin—urinary bladder cancer	5.23e-05	0.00112	CcSEcCtD
Mechlorethamine—Diarrhoea—Methotrexate—urinary bladder cancer	5.19e-05	0.00112	CcSEcCtD
Mechlorethamine—Pruritus—Epirubicin—urinary bladder cancer	5.03e-05	0.00108	CcSEcCtD
Mechlorethamine—Diarrhoea—Epirubicin—urinary bladder cancer	4.86e-05	0.00104	CcSEcCtD
Mechlorethamine—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.84e-05	0.00104	CcSEcCtD
Mechlorethamine—Vomiting—Methotrexate—urinary bladder cancer	4.83e-05	0.00104	CcSEcCtD
Mechlorethamine—Rash—Methotrexate—urinary bladder cancer	4.79e-05	0.00103	CcSEcCtD
Mechlorethamine—Dermatitis—Methotrexate—urinary bladder cancer	4.78e-05	0.00103	CcSEcCtD
Mechlorethamine—Pruritus—Doxorubicin—urinary bladder cancer	4.65e-05	0.000999	CcSEcCtD
Mechlorethamine—Vomiting—Epirubicin—urinary bladder cancer	4.52e-05	0.00097	CcSEcCtD
Mechlorethamine—Nausea—Methotrexate—urinary bladder cancer	4.51e-05	0.000969	CcSEcCtD
Mechlorethamine—Diarrhoea—Doxorubicin—urinary bladder cancer	4.5e-05	0.000966	CcSEcCtD
Mechlorethamine—Rash—Epirubicin—urinary bladder cancer	4.48e-05	0.000962	CcSEcCtD
Mechlorethamine—Dermatitis—Epirubicin—urinary bladder cancer	4.47e-05	0.000961	CcSEcCtD
Mechlorethamine—Nausea—Epirubicin—urinary bladder cancer	4.22e-05	0.000907	CcSEcCtD
Mechlorethamine—Vomiting—Doxorubicin—urinary bladder cancer	4.18e-05	0.000898	CcSEcCtD
Mechlorethamine—Rash—Doxorubicin—urinary bladder cancer	4.14e-05	0.00089	CcSEcCtD
Mechlorethamine—Dermatitis—Doxorubicin—urinary bladder cancer	4.14e-05	0.00089	CcSEcCtD
Mechlorethamine—Nausea—Doxorubicin—urinary bladder cancer	3.9e-05	0.000839	CcSEcCtD
